The Elmezzi Graduate School of Molecular Medicine and The Feinstein Institute for Medical Research are a growing force in research innovation, education and progress. We stand at the threshold of an extraordinary time in medicine.
The Feinstein Institute seeks to improve people's lives by advancing treatments and cures for illnesses and diseases. Its scientists are world-renowned in their respective fields, collaborating with scientists throughout the United States and globally. Currently, more than 125 investigators and clinical scientists are part of the Feinstein Institute, conducting research in autoimmunity, rheumatology, oncology, immunology and inflammation, genetics, psychiatry, neurology, surgery, obstetrics/gynecology and many other specialties. Through its connection to the hospital system, the Elmezzi Graduate School and The Feinstein Institute bridge the gap between biomedical research and patient care, accessing hundreds of thousands of patients in the health system's 14 hospitals, four long-term care facilities, three trauma centers, six home health agencies and dozens of outpatient facilities. The scientists of the Feinstein Institute and the students of the graduate school collaborate with physicians, dentists, medical students, fellows and residents throughout the health system to identify critical unanswered questions relating to diseases treated in the hospitals. These questions are developed into research to shed light on basic biological processes underlying disease.
The Elmezzi Graduate School of Molecular Medicine
About the Feinstein Institute for Medical Research
